LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

Search

Quanterix Corp

Închisă

SectorSănătate

7.01 5.26

Rezumat

Modificarea prețului

24h

Curent

Minim

6.53

Maxim

7.19

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-9.91% downside

Statistici piață

By TradingEconomics

Capitalizare de piață

20M

258M

Deschiderea anterioară

1.75

Închiderea anterioară

7.01

Sentimentul știrilor

By Acuity

50%

50%

151 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 nov. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

BHP Abandons Bid for Anglo American Following New Talks

23 nov. 2025, 22:16 UTC

Achiziții, Fuziuni, Preluări

Macquarie Proposes $7.5 Billion Takeover of Logistics Operator Qube

23 nov. 2025, 22:01 UTC

Achiziții, Fuziuni, Preluări

Macquarie Proposes $7.5B Takeover of Logistics Operator Qube

23 nov. 2025, 19:00 UTC

Câștiguri

Dell, HP Inc., Alibaba, Zoom, Deere, and More Stocks to Watch This Week -- Barrons.com

23 nov. 2025, 00:50 UTC

Câștiguri

Wall Street Goes on a Wild Ride: 'No One Was Expecting This' -- WSJ

22 nov. 2025, 10:30 UTC

Câștiguri

How Google Finally Leapfrogged Rivals With New Gemini Rollout -- WSJ

22 nov. 2025, 10:30 UTC

Achiziții, Fuziuni, Preluări

Investors Clamor for a Peek Behind the Private Markets Curtain -- WSJ

22 nov. 2025, 09:20 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

21 nov. 2025, 22:42 UTC

Market Talk

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21 nov. 2025, 21:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

21 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 nov. 2025, 21:47 UTC

Market Talk

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21 nov. 2025, 21:43 UTC

Market Talk

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21 nov. 2025, 20:18 UTC

Market Talk

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21 nov. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21 nov. 2025, 19:48 UTC

Market Talk

Precious Metals Fall for the Week -- Market Talk

21 nov. 2025, 19:44 UTC

Câștiguri

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21 nov. 2025, 19:37 UTC

Market Talk

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21 nov. 2025, 19:27 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

21 nov. 2025, 19:27 UTC

Market Talk
Câștiguri

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21 nov. 2025, 19:20 UTC

Market Talk

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21 nov. 2025, 18:44 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21 nov. 2025, 18:37 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21 nov. 2025, 18:34 UTC

Market Talk
Câștiguri

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21 nov. 2025, 18:28 UTC

Câștiguri

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21 nov. 2025, 18:03 UTC

Market Talk

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21 nov. 2025, 17:24 UTC

Market Talk

Global Equities Roundup: Market Talk

21 nov. 2025, 17:24 UTC

Market Talk

Intuit Seen on Path to Increase Growth -- Market Talk

21 nov. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 nov. 2025, 17:05 UTC

Market Talk

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

-9.91% jos

Prognoză pe 12 luni

Medie 6 USD  -9.91%

Maxim 7 USD

Minim 5 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

3 ratings

0

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

151 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat